Innovative Technology Biolux Research has developed proprietary Light Accelerated™ technology that enhances clinical outcomes and reduces treatment timelines in orthodontics, presenting opportunities to collaborate with dental clinics seeking cutting-edge solutions.

FDA-Cleared Products With its flagship OrthoPulse® device being FDA-cleared for use with both braces and clear aligners, there is a strong market positioning that can be leveraged to expand sales into orthodontic practices focused on efficient, non-invasive treatment options.

Recent Funding Momentum The company recently secured $14 million in Series A funding led by Venrock, indicating strong investor confidence and potential for scaling operations and expanding its distribution channels within the dental industry.

Market Position & Size Operating in the small-to-mid market segment with revenues between 1M and 10M and a dedicated focus on innovation, Biolux presents growth opportunities by targeting orthodontic clinics and dental practices investing in advanced treatment technologies.

Technology Stack & Integration Utilizing cloud services like AWS and modern web technologies, Biolux is positioned to enhance digital engagement and streamline its marketing and sales efforts, enabling better outreach and customer support for potential distribution partners.